Quinolinic acid induces neuritogenesis in SH-SY5Y neuroblastoma cells independently of NMDA receptor activation

European Journal of Neuroscience

Volumn 45, Issue 5, 2017, Pages 700-711

  Hernandez Martinez, Juan Manuel ^a   Forrest, Caroline M ^a   Darlington, L Gail ^b   Smith, Robert A ^a   Stone, Trevor W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Ashtead Hospital the Warren   (United Kingdom)

Author keywords

differentiation; glutamate; kynurenines; NAD +; nicotinamide

Indexed keywords

BETA TUBULIN; BETA3 TUBULIN; DIPHENYLIODONIUM SALT; DIZOCILPINE; DOUBLECORTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOIC ACID; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; CATION; DIZOCILPINE MALEATE; DOUBLECORTIN PROTEIN; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE; TUBULIN;

ARTICLE; CELL BODY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS; NERVE CELL; NEURITE; NEURITOGENESIS; NEUROBLASTOMA CELL LINE; PHENOTYPE; PROTEIN EXPRESSION; SH-SY5Y CELL LINE; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; NEURITE OUTGROWTH; TUMOR CELL LINE;

CELL LINE, TUMOR; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NADPH OXIDASES; NEURITES; NEURONAL OUTGROWTH; NEUROPEPTIDES; ONIUM COMPOUNDS; QUINOLINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; TRETINOIN; TUBULIN;

EID: 85010892454     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.13499     Document Type: Article

References (94)

1. Adams, S., Braidy, N., Bessesde, A., Brew, B.J., Grant, R., Teo, C. & Guillemin, G.J. (2012) The Kynurenine pathway in brain tumor pathogenesis. Cancer Res., 72, 5649–5657.
2. Bessede, A., Gargaro, M., Pallotta, M.T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S., Mazza, E.M.C. et al. (2014) Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature, 511, 184–190.
3. Bourdeaut, F., Janoueix-Lerosey, I., Lucchesi, C., Paris, R., Ribeiro, A., de Pontual, L., Amiel, J., Lyonnet, S. et al. (2009) Cholinergic switch associated with morphological differentiation in neuroblastoma. J. Pathol., 219, 463–472.
4. Buller, A.L. & Monaghan, D.T. (1997) Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes. Eur. J. Pharmacol., 320, 87–94.
5. Caron, M., Andersson, A. & Alling, C. (2000) Effects of ethanol on phosphoinositide hydrolysis and muscarinic acetylcholine receptor number in SH-SY5Y cells. Life Sci., 67, 447–456.
6. Cecchi, C., Pensalfini, A., Liguri, G., Baglioni, S., Fiorillo, C., Guadagna, S., Zampagni, M., Formigli, L. et al. (2008) Differentiation increases the resistance of neuronal cells to amyloid toxicity. Neurochem. Res., 33, 2516–2531.
7. Cheung, Y.T., Lau, W.K., Yu, M.S., Lai, C.S., Yeung, S.C., So, K.F. & Chang, R.C. (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology, 30, 127–135.
8. Chiarugi, A., Dolle, C., Felici, R. & Ziegler, M. (2012) The NAD metabolome – a key determinant of cancer cell biology. Nat. Rev. Cancer, 12, 741–752.
9. Cohen, N., Betts, D.R., Rechavi, G., Amariglio, N. & Trakhtenbrot, L. (2003) Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line. Cancer Genet. Cytogen., 143, 80–84.
10. DeCarvalho, L.P., Bochet, P. & Rossier, J. (1996) The endogenous agonist quinolinic acid and the non-endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem. Int., 28, 445–452.
11. Edsjo, A., Holmquist, L. & Pahlman, S. (2007) Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin. Cancer Biol., 17, 248–256.
12. Encinas, M., Iglesias, M., Llecha, N. & Comella, J.X. (1999) Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem., 73, 1409–1421.
13. Forrest, C.M., Khalil, O.S., Pisar, M., Darlington, L.G. & Stone, T.W. (2013a) Prenatal inhibition of the tryptophan – kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus. Brain Res., 1504, 1–15.
14. Forrest, C.M., Khalil, O.S., Pisar, M., McNair, K., Kornisiuk, E., Snitcofsky, M., Gonzalez, M., Jerusalinsky, D. et al. (2013b) Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway. Neuroscience, 254, 241–259.
15. Forrest, C.M., McNair, K., Pisar, M., Khalil, O.S., Darlington, L.G. & Stone, T.W. (2015) Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine. Neuroscience, 310, 91–105.
16. Foster, D.J., Heacock, A.M., Keep, R.F. & Fisher, S.K. (2008) Activation of muscarinic cholinergic receptors on human SH-SY5Y neuroblastoma cells enhances both the influx and efflux of K(+) under conditions of hypo-osmolarity. J. Pharmacol. Exp. Ther., 325, 457–465.
17. Fotopoulou, C., Sehouli, J., Pschowski, R., Von Haehling, S., Domanska, G., Braicu, E.-I., Fusch, G., Reinke, P. et al. (2011) Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer. Anticancer Res., 31, 2629–2635.
18. Glantz, S.B., Cianci, C.D., Iyer, R., Pradhan, D., Wang, K.K. & Morrow, J.S. (2007) Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry, 46, 502–513.
19. Guillemin, G.J., Cullen, K.M., Lim, C.K., Smythe, G.A., Garner, B., Kapoor, V., Takikawa, O. & Brew, B.J. (2007) Characterization of the kynurenine pathway in human neurons. J. Neurosci., 27, 12884–12892.
20. Heng, B., Lim, C.K., Lovejoy, D.B., Bessede, A., Gluch, L. & Guillemin, G.J. (2016) Understanding the role of the kynurenine pathway in human breast cancer immunobiology. Oncotarget, 7, 6506–6520.
21. Hinsch, N., Frank, M., Doring, C., Vorlander, C. & Hansmann, M.L. (2009) QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study. BMC Cancer, 9, 93.
22. Holen, K., Saltz, L.B., Hollywood, E., Burk, K. & Hanauske, A.R. (2008) The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest. New Drug., 26, 45–51.
23. Hong, S., Iizuka, Y., Lee, T., Kim, C. & Seong, G.J. (2014) Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress. Mol. Vis., 20, 1456–1462.
24. Huang, Q., Zhou, D., Sapp, E., Aizawa, H., Ge, P., Bird, E.D., Vonsattel, J.P. & Difiglia, M. (1995) Quinolinic acid-induced increases in calbindin-d-28k immunoreactivity in rat striatal neurons in-vivo and in-vitro mimic the pattern seen in Huntington's disease. Neuroscience, 65, 397–407.
25. Jantas, D., Pytel, M., Mozrzymas, J.W., Leskiewicz, M., Regulska, M., Antkiewicz-Michaluk, L. & Lason, W. (2008) The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int., 52, 864–877.
26. Jantas, D., Greda, A., Golda, S., Korostynski, M., Grygier, B., Roman, A., Pilc, A. & Lason, W. (2014) Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state. Neuropharmacology, 83, 36–53.
27. Khalil, O.S., Pisar, M., Forrest, C.M., Vincenten, M.C.J., Darlington, L.G. & Stone, T.W. (2014) Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring. Eur. J. Neurosci., 39, 1558–1571.
28. Kim, B., Leventhal, P.S., Saltiel, A.R. & Feldman, E.L. (1997) Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J. Biol. Chem., 272, 21268–21273.
29. Kim, D.S., An, J.M., Lee, H.G., Seo, S.R., Kim, S.S., Kim, J.Y., Kang, J.W., Bae, Y.S. et al. (2013) Activation of Rac1-dependent redox signaling is critically involved in staurosporine-induced neurite outgrowth in PC12 cells. Free Radical Res., 47, 95–103.
30. Konopka, R., Kubala, L., Lojek, A. & Pachernik, J. (2008) Alternation of retinoic acid induced neural differentiation of P19 embryonal carcinoma cells by reduction of reactive oxygen species intracellular production. Neuroendocrinol. Lett., 29, 770–774.
31. Korecka, J.A., van Kesteren, R.E., Blaas, E., Spitzer, S.O., Kamstra, J.H., Smit, A.B., Swaab, D.F., Verhaagen, J. et al. (2013) Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One, 8, e63862.
32. Kotake-Nara, E. & Saida, K. (2006) Endothelin-2/vasoactive intestinal contractor: regulation of expression via reactive oxygen species induced by CoCl2, and biological activities including neurite outgrowth in PC12 cells. Sci. World J., 6, 176–186.
33. 2 are not. Neurosci. Lett., 422, 223–227.
34. Kulikov, A.V., Rzhaninova, A.A., Goldshtein, D.V. & Boldyrev, A.A. (2007) Expression of NMDA receptors in multipotent stromal cells of human adipose tissue under conditions of retinoic acid-induced differentiation. B. Exp. Biol. Med., 144, 626–629.
35. Larsson, R., Kristensen, J., Sandberg, C. & Nygren, P. (1992) Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int. J. Cancer, 50, 177–185.
36. Lindhagen, E., Nygren, P. & Larsson, R. (2008) The fluorometric microculture cytotoxicity assay. Nat. Protoc., 3, 1364–1369.
37. Lukas, R.J., Norman, S.A. & Lucero, L. (1993) Characterization of nicotinic acetylcholine-receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell Neurosci., 4, 1–12.
38. Massudi, H., Grant, R., Guillemin, G.J. & Braidy, N. (2012) NAD(+) metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep., 17, 28–46.
39. Moffett, J.R., Els, T., Espey, M.G., Walter, S.A., Streit, W.J. & Namboodiri, M.A. (1997) Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes. Exp. Neurol., 144, 287–301.
40. Munnamalai, V. & Suter, D.M. (2009) Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth. J. Neurochem., 108, 644–661.
41. Murphy, N.P., Vaughan, P.F.T., Ball, S.G. & McCormack, J.G. (1991) The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. J. Neurochem., 57, 2116–2123.
42. Nampoothiri, M., Reddy, N.D., John, J., Kumar, N., Nampurath, G.K. & Chamallamudi, M.R. (2014) Insulin blocks glutamate-induced neurotoxicity in differentiated SH-SY5Y neuronal cells. Behav. Neurol., 2014, 674164.
43. Nicolini, G., Miloso, M., Zoia, C., Di Silvestro, A., Cavaletti, G. & Tredici, G. (1998) Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity. Anticancer Res., 18, 2477–2481.
44. Nikolova, S., Lee, Y.S., Lee, Y.S. & Kim, J.A. (2005) Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radical Res., 39, 1295–1304.
45. Nishida, Y., Adati, N., Ozawa, R., Maeda, A., Sakaki, Y. & Takeda, T. (2008) Identification and classification of genes regulated by phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways during neuronal differentiation in two subtypes of the human neuroblastoma cell line SH-SY5Y. BMC Res. Notes, 1, 95.
46. Nitti, M., Furfaro, A.L., Traverso, N., Odetti, P., Storace, D., Cottalasso, D., Pronzato, M.A., Marinari, U.M. et al. (2007) PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci. Lett., 416, 261–265.
47. Nitti, M., Furfaro, A.L., Cevasco, C., Traverso, N., Marinari, U.M., Pronzato, M.A. & Domenicotti, C. (2010) PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell differentiation. Cell. Signal., 22, 828–835.
48. Olsson, A.K., Vadhammar, K. & Nanberg, E. (2000) Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp. Cell Res., 256, 454–467.
49. Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L. et al. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature, 478, 197–203.
50. Pahlman, S., Hoehner, J.C., Nanberg, E., Hedborg, F., Fagerstrom, S., Gestblom, C., Johansson, I., Larsson, U. et al. (1995) Differentiation and survival influences of growth factors in human neuroblastoma. Eur. J. Cancer, 31A, 453–458.
51. Park, K.W., Nozell, S.E. & Benveniste, E.N. (2012) Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3. PLoS One, 7, e50874.
52. Parsons, R.B., Aravindan, S., Kadampeswaran, A., Evans, E.A., Sandhu, K.K., Levy, E.R., Thomas, M.G., Austen, B.M. et al. (2011) The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochem. J., 436, 145–155.
53. Pazdro, R. & Burgess, J.R. (2012) Differential effects of alpha-tocopherol and N-acetyl-cysteine on advanced glycation end product-induced oxidative damage and neurite degeneration in SH-SY5Y cells. Biochim. Biophys. Acta, 1822, 550–556.
54. Perkins, M.N. & Stone, T.W. (1982) An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res., 247, 184–187.
55. Perkins, M.N. & Stone, T.W. (1983) The pharmacology and regional variations of quinolinic acid evoked excitations in the rat CNS. J. Pharmacol. Exp. Ther., 226, 551–557.
56. Pierozan, P., Zamoner, A., Soska, A.K., de Lima, B.O., Reis, K.P., Zamboni, F., Wajner, M. & Pessoa-Pureur, R. (2012) Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes. Exp. Neurol., 233, 391–399.
57. Pierozan, P., Ferreira, F., de Lima, B.O. & Pessoa-Pureur, R. (2015) Quinolinic acid induces disrupts cytoskeletal homeostasis in striatal neurons. Protective role of astrocyte-neuron interaction. J. Neurosci. Res., 93, 268–284.
58. Piras, S., Furfaro, A.L., Domenicotti, C., Traverso, N., Marinari, U.M., Pronzato, M.A. & Nitti, M. (2016) RAGE expression and ROS generation in neurons: differentiation versus damage. Oxid. Med. Cell. Longev., 2016, 9348651.
59. Pisar, M., Forrest, C.M., Khalil, O.S., McNair, K., Vincenten, M.C.J., Qasem, S., Darlington, L.G. & Stone, T.W. (2014) Modified neocortical and cerebellar protein expression and morphology following prenatal inhibition of the kynurenine pathway. Brain Res., 1576, 1–17.
60. Pittaluga, A., Pattarini, R., Feligioni, M. & Raiteri, M. (2001) N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. J. Neurochem., 76, 139–148.
61. Pizzi, M., Boroni, F., Bianchetti, A., Moraitis, C., Sarnico, I., Benarese, M., Goffi, F., Valerio, A. et al. (2002) Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur. J. Neurosci., 16, 2342–2350.
62. Prendergast, G.C. (2011) Cancer: why tumours eat tryptophan. Nature, 478, 192–194.
63. Priestley, T., Laughton, P., Myers, J., Lebourdelles, B., Kerby, J. & Whiting, P.J. (1995) Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1A/NR2A and NR1A/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol., 48, 841–848.
64. Pucetti, P., Fallarino, F., Italiano, A., Soubeyran, I., MacGrogan, G., Debled, M., Velasco, V., Bodet, D. et al. (2015) Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers. PLoS One, 10, e0122046.
65. Rios, C. & Santamaria, A. (1991) Quinolinic acid: a potent lipid peroxidant in rat-brain homogenates. Neurochem. Res., 16, 1139–1143.
66. Sagan, D., Kocki, T., Kocki, J. & Szumilo, J. (2012) Serum kynurenic acid: possible association with invasiveness of non-small cell lung cancer. Asian Pac. J. Cancer P., 13, 4241–4244.
67. Sahm, F., Oezen, I., Opitz, C.A., Radlwimmer, B., von Deimling, A., Ahrendt, T., Adams, S., Bode, H.B. et al. (2013) The endogenous tryptophan metabolite and NAD(+) precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res., 73, 3225–3234.
68. Santamaria, A., Galvan-Arzate, S., Lisy, V., Ali, S.F., Duhart, H.M., Osorio-Rico, L., Rios, C. & St'astny, F. (2001) Quinolinic acid induces oxidative stress in rat brain synaptosomes. NeuroReport, 12, 871–874.
69. Sayin, V.I., Ibrahim, M.X., Larsson, E., Nilsson, J.A., Lindahl, P. & Bergo, M.O. (2014) Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med., 6, 221ra15.
70. Schliebs, R., Heidel, K., Apelt, J., Gniezdzinska, M., Kirazov, L. & Szutowicz, A. (2006) Interaction of interleukin-1 beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells. Brain Res., 1122, 78–85.
71. Schneider, L., Giordano, S., Zelickson, B.R., Johnson, M.S., Benavides, G.A., Ouyang, X.S., Fineberg, N., Darley-Usmar, V.M. et al. (2011) Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. Free Radical Bio. Med., 51, 2007–2017.
72. Schuller, H.M. (2008) Neurotransmission and cancer: implications for prevention and therapy. Anticancer Drugs, 19, 655–671.
73. Schwarcz, R., Whetsell, W.O. & Mangano, R.M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science, 219, 316–318.
74. Stastny, F., Tejkalova, H., Skuba, I., Palenicek, T., Mares, V., Klaschka, J. & Balcar, V.J. (2005) Quinolinic acid alters hippocampal levels of glutamate and NR2B subunit of NMDA receptor: a developmental model of schizophrenia. J. Neurochem., 94, 230 (abst).
75. Stipek, S., Stastny, F., Platenik, J., Crkovska, J. & Zima, T. (1997) The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem. Int., 30, 233–237.
76. Stone, T.W. & Darlington, L.G. (2002) Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discov., 1, 609–620.
77. Stone, T.W. & Perkins, M.N. (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol., 72, 411–412.
78. Stone, T.W., Stoy, N. & Darlington, L.G. (2013) An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol. Sci., 34, 136–143.
79. Sun, Z.-W., Zhang, L., Zhu, S.-J., Chen, W.-C. & Mei, B. (2010) Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage. Neurosci. Bull., 26, 8–16.
80. Tetich, M., Kutner, A., Leskiewicz, M., Budziszewska, B. & Lason, W. (2004) Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. J. Steroid Biochem., 89, 365–370.
81. Thaker, A.I., Rao, M.S., Bishnupuri, K.S., Kerr, T.A., Foster, L., Marinshaw, J.M., Newberry, R.D., Stenson, W.F. et al. (2013) IDO1 metabolites activate beta-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. Gastroenterology, 145, 416–425.
82. Thomas, M.G., Saldanha, M., Mistry, R.J., Dexter, D.T., Ramsden, D.B. & Parsons, R.B. (2013) Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling. Cell Death Dis., 4, e669.
83. Tohda, C., Nakamura, N., Komatsu, K. & Hattori, M. (1999) Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol. Pharm. Bull., 22, 679–682.
84. Travelli, C., Drago, V., Maldi, E., Kaludercic, N., Galli, U., Boldorini, R., Di Lisa, F., Tron, G.C. et al. (2011) Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells. J. Pharmacol. Exp. Ther., 338, 829–840.
85. Uberti, D., Rizzini, C., Galli, P., Pizzi, M., Grilli, M., Lesage, A., Spano, P. & Memo, M. (1997) Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. Synapse, 26, 95–103.
86. Valencia, A. & Moran, J. (2004) Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radical Bio. Med., 36, 1112–1125.
87. Walczak, K., Dabrowski, W., Langner, E., Zgrajka, W., Pilat, J., Kocki, T., Rzeski, W. & Turski, W.A. (2011) Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand. J. Gastroentero., 46, 903–912.
88. Walczak, K., Zurawska, M., Kis, J., Starownik, R., Zgrajka, W., Bar, K., Turski, W.A. & Rzeski, W. (2012) Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells. Amino Acids, 43, 1663–1670.
89. Walczak, K., Turski, W.A. & Rajtar, G. (2014a) Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways. Amino Acids, 46, 2393–2401.
90. Walczak, K., Deneka-Hannemann, S., Jarosz, B., Zgrajka, W., Stoma, F., Trojanowski, T., Turski, W.A. & Rzeski, W. (2014b) Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells. Pharmacol. Rep., 66, 130–136.
91. Weinreb, O., Amit, T., Mandel, S. & Youdim, M.B.H. (2009) Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr., 4, 283–296.
92. Willets, J.M., Challiss, R.A.J. & Nahorski, S.R. (2002) Endogenous G protein-coupled receptor kinase 6 regulates M-3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J. Biol. Chem., 277, 15523–15529.
93. Wilson, C. & Gonzalez-Billault, C. (2015) Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Front. Cell. Neurosci., 9, 381.
94. Wszelaki, N. & Melzig, M.F. (2011) Research on an in vitro cell system for testing the neurotoxicity of kynurenine pathway metabolites. Pharmazie, 66, 899–903.